Creative Medical Technology Holdings Inc (NASDAQ: CELZ)’s stock price has soared by 18.61 in relation to previous closing price of 3.17. Nevertheless, the company has seen a gain of 19.37% in its stock price over the last five trading days. globenewswire.com reported 2025-01-30 that PHOENIX, Jan. 30, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on regenerative medicine, today announced promising initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the Company’s proprietary stem cell-based therapeutic for the treatment of chronic back pain caused by degenerative disc disease (DDD).
Is It Worth Investing in Creative Medical Technology Holdings Inc (NASDAQ: CELZ) Right Now?
CELZ has 36-month beta value of 4.70. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CELZ is 1.71M, and currently, short sellers hold a 1.05% ratio of that float. The average trading volume of CELZ on February 05, 2025 was 43.07K shares.
CELZ’s Market Performance
CELZ stock saw an increase of 19.37% in the past week, with a monthly gain of 62.77% and a quarterly increase of -9.18%. The volatility ratio for the week is 14.31%, and the volatility levels for the last 30 days are 11.75% for Creative Medical Technology Holdings Inc (CELZ). The simple moving average for the past 20 days is 43.13% for CELZ’s stock, with a 10.29% simple moving average for the past 200 days.
CELZ Trading at 51.66% from the 50-Day Moving Average
After a stumble in the market that brought CELZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.43% of loss for the given period.
Volatility was left at 11.75%, however, over the last 30 days, the volatility rate increased by 14.31%, as shares surge +54.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +49.21% upper at present.
During the last 5 trading sessions, CELZ rose by +19.37%, which changed the moving average for the period of 200-days by -24.72% in comparison to the 20-day moving average, which settled at $2.63. In addition, Creative Medical Technology Holdings Inc saw 62.77% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CELZ
Current profitability levels for the company are sitting at:
- -511.82 for the present operating margin
- -7.04 for the gross margin
The net margin for Creative Medical Technology Holdings Inc stands at -483.45. The total capital return value is set at -0.86. Equity return is now at value -57.03, with -54.82 for asset returns.
Currently, EBITDA for the company is -5.53 million with net debt to EBITDA at 1.15. When we switch over and look at the enterprise to sales, we see a ratio of 28.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 19.13.
Conclusion
To put it simply, Creative Medical Technology Holdings Inc (CELZ) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
